Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05465018
Other study ID # ICBE-S-000822
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 7, 2022
Est. completion date September 30, 2022

Study information

Verified date August 2022
Source Philips Clinical & Medical Affairs Global
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This Performance Assessment Study will focus on testing the performance of the VitalSigns Camera under various suboptimal use cases. The software makes it possible to measure the pulse rate (PR) and respiration rate (RR) without the device being in contact with the subject. The software delivers fast and accurate results (in less than one minute). Vital signs camera (VSC) product will be used via a demonstrator app on one of the smartphones during the study sessions (camera of the phone will be used by the VSC product). Devices will be provided by the researchers. The subject will be asked to perform a number of assignments with the software application. The study involves taking a number of measurements of the subject's PR using the VitalSigns Camera software application (which is installed on a smartphone or laptop). In this study only PR is measured and not RR as the latter parameter is not affected by the designed test cases. The total duration of the session will be approximately 1 hour. In total, approximately 30 healthy volunteers will participate in this study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date September 30, 2022
Est. primary completion date July 22, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Healthy volunteer must 18 years or older - Participants willing to give informed consent - Willingness to have vital signs measured by a medical mobile application - Willingness to put on sunglasses - Willingness to put on facial makeup - Willingness to put on a face mask covering mouth and nose - Willingness to sit still up to 2 minutes per measurement Exclusion Criteria: - Individuals who are not able to read and understand the English language - Known allergic reaction to facial make-up - COVID-19 exclusion criteria: - Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing - Having been positively tested as infected with COVID-19 in the past 14 days - Travelled to or from high risk COVID-19 areas in the past 14 days - Been in contact with a (suspected) COVID-infected person in the past 14 days

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Happy Flow / Baseline
Baseline (without make-up or mask)
Make-up
To test device on participant who is wearing facial make-up
Sunglasses
To test device on participant who is wearing sunglasses
Face mask
To test device on participant who is wearing a facial mask
Minimum requirements camera
To test the minimum requirements of the camera
Worst case hardware
To test if software still works with an older smartphone
Damaged lens
To test if software is still working when the lens of the smartphone is damaged
Face or chest outside test frame
To test software if the participants face or chest is outside the test frame

Locations

Country Name City State
United States Philips Research North America Cambridge Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Philips Clinical & Medical Affairs Global

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary endpoint To compare the Pulse Rate (Beats per Minute) measured by the VitalSigns Camera with the Pulse Rate measured by the reference device. Each participants will have measurement for 1 hour on 1 day. Study will be completed within 1 week.
See also
  Status Clinical Trial Phase
Completed NCT01398176 - Immune Benefits From Mushroom Consumption N/A
Completed NCT01248442 - Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans Phase 4
Completed NCT00345215 - The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans. N/A
Completed NCT01716910 - Effect of Synbiotic on Composition of Human Gut Microbiota and Production of Short and Branched-chain Fatty Acids Phase 0
Completed NCT01398150 - Cranberry Enhances Human Immune Function and Reduces Illness N/A
Completed NCT02291536 - Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) N/A